Skip to main content
Marc Rothenberg, MD, Allergy & Immunology, Cincinnati, OH

MarcERothenbergMD

Allergy & Immunology • Cincinnati, OH

Pediatric Asthma & Allergic Conditions

Professor, Pediatrics, University of Cincinnati College of Medicine

Join to view full profile

Dr. Rothenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rothenberg's full profile

Already have an account?

  • Office

    3333 Burnet Ave
    # MLC2000
    Cincinnati, OH 45229
    Phone+1 513-636-6771
    Fax+1 513-636-2511

Education & Training

  • Boston Children’s Hospital
    Boston Children’s HospitalFellowship, Allergy and Immunology, 1992 - 1994
  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1990 - 1992
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1997 - 2026
  • MA State Medical License
    MA State Medical License 1992 - 1997
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2000
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Variants at the 16p13 Locus Confer Risk for Eosinophilic Esophagitis  
    Robert P Kimberly, Marc E Rothenberg, Patrick M Gaffney, Hugh A Sampson, J Pablo Abonia, Mirna Chehade, Philip E Putnam, Brian P Vickery, Glenn T Furuta, John B Harley, Nature

Press Mentions

  • In EoE, Esophageal Protein Profiles Appear Similar Between PPI-Responsive and Nonresponsive Patients Before Treatment
    In EoE, Esophageal Protein Profiles Appear Similar Between PPI-Responsive and Nonresponsive Patients Before TreatmentDecember 18th, 2024
  • Native American Children, Young Adults with Eosinophilic Esophagitis See Barriers in Care
    Native American Children, Young Adults with Eosinophilic Esophagitis See Barriers in CareOctober 15th, 2024
  • Milk Elimination Diet Shows Promise as First-Line Therapy for Children with EoE
    Milk Elimination Diet Shows Promise as First-Line Therapy for Children with EoESeptember 6th, 2024
  • Join now to see all

Grant Support

  • Regulation Of Gastrointestinal EosinophilsNational Institute Of Allergy And Infectious Diseases2010–2012
  • Role Of Desmoglein-1 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2011
  • IL-13 And Eosinophilic EsophagitisNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • IL-13 Associated Eosinophil Lung ResponsesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Eosinophilic Esophagitis And Food AllergyNational Institute Of Allergy And Infectious Diseases2010–2011
  • Epithelial-Derived Eotaxin 3 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2010
  • A Multi-Center Clinical Trial Of 1760 MCG Of Daily Swallowed Fluticasone Vs. PlacNational Institute Of Allergy And Infectious Diseases2010
  • IL-13 Associated Eosinophil Lung ResponsesNational Institute Of Allergy And Infectious Diseases2009
  • A Multi-Center Clinical Trial Of 1760 MCG Of Daily Swallowed Fluticasone Vs. PlacNational Institute Of Allergy And Infectious Diseases2009
  • IL-13 And Eosinophilic EsophagitisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2009
  • Epithelial-Derived Eotaxin 3 In Eosinophilic EsophagitisNational Institute Of Allergy And Infectious Diseases2006–2009
  • Clinical Trial: Effect Of Intravenous Anti-Il5 (MEPOLIZUMAB) In HypereosinophiliNational Center For Research Resources2008
  • Regulation Of Gastrointestinal EosinophilisNational Institute Of Allergy And Infectious Diseases2004–2008
  • Role Of Eotaxins And CCR3 In IL-13 Induced AsthmaNational Heart, Lung, And Blood Institute2004–2008
  • Core--Breeding And GenotypingNational Heart, Lung, And Blood Institute2004–2008
  • Effect Of Intravenous Anti-Il5 (MEPOLIZUMAB) In Hypereosinophilic SyndromesNational Center For Research Resources2005–2007
  • Eosinophil, Chemokine And IL-13 Cooperativity In AsthmaNational Institute Of Allergy And Infectious Diseases2004–2007
  • Role Of Arginase In Allergic Airway InflammationNational Institute Of Allergy And Infectious Diseases2003–2007
  • Anti-Il 5 For HypereosinophiliaFood And Drug Administration2005
  • IV Anti-Il5 (MEPOLIZUMAB) In Hypereosinophilic SyndromesNational Center For Research Resources2004
  • Regulation Of Gastrointestinal EosinophilsNational Institute Of Allergy And Infectious Diseases1999–2002
  • Mechanisms Of Eosinophilia In Experimental AsthmaNational Institute Of Allergy And Infectious Diseases1998–2002

Professional Memberships

Dr. Marc Rothenberg, Dr. Marc Rothenberg, MD, Dr. M Rothenberg, Dr. Marc E Rothenberg